Liposomal form of desferal as an effective chlamidial agent
Abstract
About the Authors
N. V. RukosuevaRussian Federation
D. A. Zakharova
Russian Federation
D. A. Bezrykov
Russian Federation
A. P. Kaplun
Russian Federation
V. I. Shvets
Russian Federation
N. A. Zigangirova
Russian Federation
References
1. Карягина А.С., Алексеевский А.В., Спирин С.А., Зигангирова Н.А., Гинцбург А.Л. Эффекторные белки хламидий // Мол. биология. 2009. Т. 43. Вып. 6. С. 963–983.
2. Dean D. Chlamydia trachomatis today: Treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis // Drugs Today. 2009. V. 25 (supple B). P. 25–31.
3. Raulston J. E. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins // Infect. Immun. 1999. V. 65. P. 4539–4547.
4. Chaston T.B., Richardson R. Iron chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity // Amer. J. Hematology. 2003. V. 73. P. 200–210.
5. Al-Younes H.M., Rudel T., Brinkmann V., Szczepek A.J., Meyer T.F. Low iron availability modulates the course of Chlamydia pneumoniae infection // Cell. Microbiol. 2001. V. 3. № 6. P. 427–437.
6. Kim H.J., Hida H., Jung C.G., Miura Y., Nishino H. Treatment with deferoxamine increases neurons from neural stem/progenitor cells // Brain Res. 2006. V. 1092. № 1. P. 1–15.
7. Швец В.И., Каплун А.П., Краснопольский Ю.М., Степанов А.Е., Чехонин В.П. От липосом семидесятых к наночастицам XXI века // Рос. нанотехнологии. 2008. Т. 3. № 11-12. С. 6–20.
Review
For citations:
Rukosueva N.V., Zakharova D.A., Bezrykov D.A., Kaplun A.P., Shvets V.I., Zigangirova N.A. Liposomal form of desferal as an effective chlamidial agent. Fine Chemical Technologies. 2012;7(6):22-26. (In Russ.)